Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The stock, which is currently worth 2024 to 0.68 times its sales, is clearly overvalued in comparison with peers.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● Over the past four months, analysts' average price target has been revised upwards significantly.


Weaknesses

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.